Escitalopram (CAS 128196-01-0) Antidepressant Pharmaceutical API

Escitalopram (CAS 128196-01-0) is a potent selective serotonin reuptake inhibitor (SSRI) antidepressant API, renowned for its targeted action on central nervous system serotonin regulation. Its unique molecular structure selectively blocks serotonin reuptake transporters, increasing synaptic serotonin levels to alleviate depressive symptoms, anxiety, and obsessive-compulsive behaviors. This high-purity pharmaceutical raw material complies with strict international pharmacopoeial standards, ensuring consistent potency and stability for clinical formulation.

Widely utilized in psychiatric drug development, it serves as a core ingredient for medications treating major depressive disorder, generalized anxiety disorder, and social anxiety disorder. Valued for its favorable safety profile, rapid onset of therapeutic effects, and minimal side effects compared to traditional antidepressants, it addresses critical unmet needs for patients with mood and anxiety disorders. Choose this trusted antidepressant API to develop high-quality formulations that improve mental health and enhance patients’ quality of life.